SBRA Quote, Financials, Valuation and Earnings

LTC Properties has a net margin of 25.61% compared to Sabra Health Care REIT's net margin of 34.39%. Sabra Health Care REIT's return on equity of 4.59% beat LTC Properties's return on equity of 9.27%.

Sabra Health Care REIT has a consensus price target of $19.67, signalling upside risk potential of 13.81%. On the other hand LTC Properties has an analysts' consensus of $37.29 which suggests that it could grow by 7.48%. Given that Sabra Health Care REIT has higher upside potential than LTC Properties, analysts believe Sabra Health Care REIT is more attractive than LTC Properties.

Sabra Health Care REIT has a beta of 0.936, which suggesting that the stock is 6.362% less volatile than S&P 500. In comparison LTC Properties has a beta of 0.746, suggesting its less volatile than the S&P 500 by 25.441%.

Sabra Health Care REIT has a quarterly dividend of $0.30 per share corresponding to a yield of 6.94%. LTC Properties offers a yield of 6.57% to investors and pays a quarterly dividend of $0.19 per share. Sabra Health Care REIT pays 221.09% of its earnings as a dividend. LTC Properties pays out 110.42% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Sabra Health Care REIT quarterly revenues are $182.3M, which are larger than LTC Properties quarterly revenues of $52.6M. Sabra Health Care REIT's net income of $46.7M is higher than LTC Properties's net income of $18.1M. Notably, Sabra Health Care REIT's price-to-earnings ratio is 32.60x while LTC Properties's PE ratio is 16.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sabra Health Care REIT is 5.80x versus 7.29x for LTC Properties. Usually stocks with elevated PS ratios are considered overvalued.

Office Properties Income Trust has a net margin of 25.61% compared to Sabra Health Care REIT's net margin of -125.75%. Sabra Health Care REIT's return on equity of 4.59% beat Office Properties Income Trust's return on equity of -10.86%.

Sabra Health Care REIT has a consensus price target of $19.67, signalling upside risk potential of 13.81%. On the other hand Office Properties Income Trust has an analysts' consensus of $0.75 which suggests that it could grow by 97.37%. Given that Office Properties Income Trust has higher upside potential than Sabra Health Care REIT, analysts believe Office Properties Income Trust is more attractive than Sabra Health Care REIT.

Sabra Health Care REIT has a beta of 0.936, which suggesting that the stock is 6.362% less volatile than S&P 500. In comparison Office Properties Income Trust has a beta of 1.583, suggesting its more volatile than the S&P 500 by 58.284%.

Sabra Health Care REIT has a quarterly dividend of $0.30 per share corresponding to a yield of 6.94%. Office Properties Income Trust offers a yield of 10.53% to investors and pays a quarterly dividend of $0.01 per share. Sabra Health Care REIT pays 221.09% of its earnings as a dividend. Office Properties Income Trust pays out -1.49% of its earnings as a dividend.

Sabra Health Care REIT quarterly revenues are $182.3M, which are larger than Office Properties Income Trust quarterly revenues of $118.2M. Sabra Health Care REIT's net income of $46.7M is higher than Office Properties Income Trust's net income of -$148.7M. Notably, Sabra Health Care REIT's price-to-earnings ratio is 32.60x while Office Properties Income Trust's PE ratio is 8.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sabra Health Care REIT is 5.80x versus 0.04x for Office Properties Income Trust. Usually stocks with elevated PS ratios are considered overvalued.

Pebblebrook Hotel Trust has a net margin of 25.61% compared to Sabra Health Care REIT's net margin of -14.95%. Sabra Health Care REIT's return on equity of 4.59% beat Pebblebrook Hotel Trust's return on equity of -0.15%.

Sabra Health Care REIT has a consensus price target of $19.67, signalling upside risk potential of 13.81%. On the other hand Pebblebrook Hotel Trust has an analysts' consensus of $13.88 which suggests that it could grow by 64.71%. Given that Pebblebrook Hotel Trust has higher upside potential than Sabra Health Care REIT, analysts believe Pebblebrook Hotel Trust is more attractive than Sabra Health Care REIT.

Sabra Health Care REIT has a beta of 0.936, which suggesting that the stock is 6.362% less volatile than S&P 500. In comparison Pebblebrook Hotel Trust has a beta of 1.688, suggesting its more volatile than the S&P 500 by 68.813%.

Sabra Health Care REIT has a quarterly dividend of $0.30 per share corresponding to a yield of 6.94%. Pebblebrook Hotel Trust offers a yield of 0.48% to investors and pays a quarterly dividend of $0.01 per share. Sabra Health Care REIT pays 221.09% of its earnings as a dividend. Pebblebrook Hotel Trust pays out -1226.97% of its earnings as a dividend.

Sabra Health Care REIT quarterly revenues are $182.3M, which are smaller than Pebblebrook Hotel Trust quarterly revenues of $337.6M. Sabra Health Care REIT's net income of $46.7M is higher than Pebblebrook Hotel Trust's net income of -$50.5M. Notably, Sabra Health Care REIT's price-to-earnings ratio is 32.60x while Pebblebrook Hotel Trust's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sabra Health Care REIT is 5.80x versus 0.78x for Pebblebrook Hotel Trust. Usually stocks with elevated PS ratios are considered overvalued.

Ventas has a net margin of 25.61% compared to Sabra Health Care REIT's net margin of 4.42%. Sabra Health Care REIT's return on equity of 4.59% beat Ventas's return on equity of 0.81%.

Sabra Health Care REIT has a consensus price target of $19.67, signalling upside risk potential of 13.81%. On the other hand Ventas has an analysts' consensus of $75.95 which suggests that it could grow by 15.93%. Given that Ventas has higher upside potential than Sabra Health Care REIT, analysts believe Ventas is more attractive than Sabra Health Care REIT.

Sabra Health Care REIT has a beta of 0.936, which suggesting that the stock is 6.362% less volatile than S&P 500. In comparison Ventas has a beta of 1.017, suggesting its more volatile than the S&P 500 by 1.691%.

Sabra Health Care REIT has a quarterly dividend of $0.30 per share corresponding to a yield of 6.94%. Ventas offers a yield of 2.79% to investors and pays a quarterly dividend of $0.48 per share. Sabra Health Care REIT pays 221.09% of its earnings as a dividend. Ventas pays out 912.26% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Sabra Health Care REIT quarterly revenues are $182.3M, which are smaller than Ventas quarterly revenues of $1.3B. Sabra Health Care REIT's net income of $46.7M is lower than Ventas's net income of $56.8M. Notably, Sabra Health Care REIT's price-to-earnings ratio is 32.60x while Ventas's PE ratio is 344.79x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sabra Health Care REIT is 5.80x versus 5.54x for Ventas. Usually stocks with elevated PS ratios are considered overvalued.